Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

BACKGROUND: In studying the therapeutic evidence of innovative drug treatments, increasing attention is being devoted to differentiating between results that indicate no significant differences among the treatments under examination (“no proof of difference”) and results that demonstrate the therape...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2014
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4065299/
https://ncbi.nlm.nih.gov/pubmed/24793219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0066-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak